earnings

This Diabetes Company's Q1 Earnings Reflect the Resiliency of Its Business Model
Motley Fool
Mon, 06/1/20 - 10:34 am
Insulet
diabetes
devices
insulin pumps
earnings
Here's Why Editas Could Beat Intellia to a CRISPR Therapy
Motley Fool
Fri, 05/22/20 - 10:30 am
gene editing
CRISPR
Editas Medicine
Intellia
earnings
Medtronic misses mark in Q4 as sales decline 26%
Mass Device
Thu, 05/21/20 - 11:17 pm
Medtronic
devices
earnings
Is Amyris Finally Turning a Corner?
Motley Fool
Thu, 05/14/20 - 10:20 am
Amyris
earnings
synthetic biology
Takeda posts surprise profit a year after Shire mega-merger
Pharmaforum
Wed, 05/13/20 - 10:52 am
Japan
Takeda
Shire
M&A
earnings
AMAG Pharma to Lay Off 140 Staffers as Part of Company Restructure
BioSpace
Tue, 05/12/20 - 05:13 pm
Amag Pharmaceuticals
earnings
layoffs
How GW Pharmaceuticals Hit a Home Run in Q1
Motley Fool
Tue, 05/12/20 - 11:48 am
GW Pharma
earnings
Epidiolex
What's Behind Mylan's Mixed Q1 Results
Motley Fool
Mon, 05/11/20 - 11:38 pm
Mylan
Pfizer
Upjohn
M&A
Viatris
earnings
Endo International Fires on All Cylinders in Q1 Thanks to COVID-19 Impact
Motley Fool
Thu, 05/7/20 - 10:27 pm
Endo International
earnings
Neurocrine Biosciences Q1 Beats on Earnings, Revenue
Motley Fool
Thu, 05/7/20 - 10:24 pm
Neurocrine
earnings
Here's Why Teva Pharmaceuticals Jumped Higher Today
Motley Fool
Thu, 05/7/20 - 10:21 pm
Teva Pharmaceutical
earnings
3 Reasons Bristol Myers Squibb's Revenue Skyrocketed in Q1
Motley Fool
Thu, 05/7/20 - 11:03 am
Bristol-Myers Squibb
earnings
Zoetis Beats Expectations in Q1 but Lowers Full-Year Outlook Due to COVID-19
Motley Fool
Thu, 05/7/20 - 12:28 am
Zoetis
earnings
animal health
Why Jazz Pharmaceuticals Sang Off-Key in Q1
Motley Fool
Wed, 05/6/20 - 12:03 pm
Jazz Pharmaceuticals
earnings
Regeneron Says Its COVID-19 Combo Treatment Could Be Ready for People This Fall
Motley Fool
Wed, 05/6/20 - 12:02 pm
Regeneron
COVID-19
REGN-COV2
earnings
clinical trials
Why Mallinckrodt Stock Tumbled Today
Motley Fool
Tue, 05/5/20 - 11:54 pm
Mallinckrodt
earnings
Why Incyte's Q1 Loss Isn't As Bad As It Looks
Motley Fool
Tue, 05/5/20 - 11:52 pm
Incyte
earnings
AbbVie Beats Q1 Estimates as U.S. Humira Sales Rise 13.7%
Motley Fool
Fri, 05/1/20 - 12:21 pm
AbbVie
earnings
3 Big Stories in Gilead Sciences' Q1 Results
Motley Fool
Fri, 05/1/20 - 11:04 am
earnings
Gilead Sciences
remdesivir
COVID-19
Abiomed stock up amid Street-beating Q4 profits, news of Breethe acquisition
Mass Device
Thu, 04/30/20 - 10:45 am
Abiomed
devices
earnings
M&A
Breethe
ECMO
COVID-19
pandemic

Pages